Business Wire

Vantage Data Centers Expands European Footprint with Second Italian Campus

15.10.2025 14:00:00 CEST | Business Wire | Press Release

Share

Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced the expansion of its Italian footprint to include a second campus in Milan. With an investment of more than €350 million (approximately $407 million USD), the MXP2 campus is designed to support the growing demand for high-performance, scalable digital infrastructure in the country.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015151520/en/

Vantage Data Centers’ growing Italian footprint includes a second Milan campus with 32MW of IT capacity.

Located in Castelletto just 15 kilometers (less than 10 miles) from central Milan, the campus will feature two modern data centers delivering a combined 32MW of critical IT capacity across approximately 10,000 square meters (108,000 square feet). The first phase is slated to be operational in the spring of 2026.

“Expanding our Italian footprint in Greater Milan marks a strategic move for Vantage. Milan’s extensive fiber network and position along major terrestrial backbones provide low-latency connectivity to key European hubs, including Zurich, Frankfurt and Munich,” said David Howson, president, EMEA at Vantage Data Centers. “The region’s expanding digital ecosystem and competitive market dynamics make it an ideal location for global hyperscale growth, and our investment in MXP2 underscores Vantage’s commitment to delivering world-class, sustainable data center solutions in this key market to enable cloud and AI technologies.”

Vantage’s initial investment in Milan with its MXP1 campus laid the foundation for the company’s continued growth in the region, and the addition of MXP2 further reinforces this commitment.

Vantage’s multiple campus developments were recently recognized by the Italian Government under Article 13 of Decree Law 104/2023 as nationally strategic infrastructure investments supporting the country’s economic agenda. Through this program, Vantage will invest approximately €4 billion (approximately $4.6 billion USD) and employ an estimated 4,000 workers over eight years during construction, while also creating approximately 250 permanent jobs.

As stated by the Italian Council of Ministers on October 2, Vantage’s investment in Italy is “considered to be in the public interest as it aims to harness the potential of digital technologies, stimulate innovation and support economic growth in Europe; strengthen the country’s role in the European energy transition and digital resilience strategy; offer new skilled job opportunities and attract investment in research and development; promote innovative long-term projects capable of generating a lasting impact in the regions where they operate; improve essential infrastructure such as transport networks, energy networks and advanced connectivity services.”

“Vantage appreciates the recognition from the Italian government to be part of the growth engine powering the next generation of technology in my country,” said Alfonso Romano, vice president, site selection and acquisition, EMEA at Vantage Data Centers. “Our investments not only enable digital transformation but also positively contribute to a growing economy, job creation, innovation and sustainable opportunities for local communities.”

MXP2 is designed with sustainability at its core, integrating seven types of nature-based solutions (NbS), including permeable surfaces, sustainable urban drainage, vertical greenery, rain gardens, infiltration basins and landscape integration to manage stormwater sustainably. Additionally, the campus will feature a multi-species mitigation strip of a variety of trees, along with flowering rustic meadows, enhancing the local ecosystem and supporting phytoremediation.

Combined with MXP1, Vantage’s Italian footprint to date will include a total of 96MW of IT capacity to support some of today’s leading technology companies.

About Vantage Data Centers

Vantage Data Centers is a global leader in digital infrastructure serving the world’s most influential AI and cloud providers. With operations spanning North America, EMEA and Asia Pacific, Vantage delivers capacity at unrivaled speed and scale, driven by a relentless commitment to operational excellence and customer success. Vantage is empowering transformative companies to shape the future.

For more information about Vantage Data Centers, visit http://www.vantage-dc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251015151520/en/

Contacts

Press Contacts
Mark Freeman
Vantage Data Centers
mfreeman@vantage-dc.com
+1-202-680-4243

Robin Bectel
REQ for Vantage Data Centers
vdc@req.co
+1-202-936-6335

Ágota Dόzsa
Barabino & Partners S.r.l. for Vantage Data Centers
a.dozsa@barabino.it
+39 02/72-02-35-35

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye